Known targets — ChEMBL curated mechanism
ACHEBDKRB2CHRM1CHRM2CHRM3CHRNA1CHRNB1CHRNDCHRNECHRNGGUCY1A1GUCY1A2GUCY1B1GUCY1B2NAMPTPTAFRSLC10A2SLC6A2SLC6A3TACR1dacAdacBdacCftsImrcAmrcBmrdA
The experimentally established mechanism targets of Hydrochloric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 1/20 | 0.62 |
| ▸ | SLC5A7 | Q9GZV3 | 1/20 | 0.62 |
| ▸ | MEN1 | O00255 | 1/20 | 0.53 |
| ▸ | LMNA | P02545 | 1/20 | 0.53 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.53 |
| ▸ | PSMD14 | O00487 | 1/20 | 0.41 |
| ▸ | PLA2G1B | P04054 | 1/20 | 0.41 |
| ▸ | MMP2 | P08253 | 1/20 | 0.41 |
| ▸ | RAD52 | P43351 | 1/20 | 0.41 |
| ▸ | ATG4B | Q9Y4P1 | 1/20 | 0.41 |
| ▸ | DNM1 | Q05193 | 2/20 | 0.38 |
| ▸ | APEX1 | P27695 | 1/20 | 0.32 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL15546645 | 0.96 | CYP3A4 (0.59) | CYP3A4SLC5A7MEN1LMNAKMT2A | |
| Hydrochloric Acid SCHEMBL15754070 | 0.96 | CYP3A4 (0.59) | CYP3A4SLC5A7MEN1LMNAKMT2A | |
| SCHEMBL159367 | 0.96 | MEN1 (0.56) | CYP3A4SLC5A7MEN1LMNAKMT2A | |
| SCHEMBL10416316 | 0.92 | MEN1 (0.53) | CYP3A4SLC5A7MEN1LMNAKMT2A | |
| Bromide SCHEMBL15820401 | 0.92 | MEN1 (0.62) | CYP3A4SLC5A7MEN1LMNAKMT2A | |
| Water SCHEMBL490994 | 0.92 | MEN1 (0.53) | CYP3A4SLC5A7MEN1LMNAKMT2A | |
| SCHEMBL8995906 | 0.92 | MEN1 (0.53) | CYP3A4SLC5A7MEN1LMNAKMT2A | |
| SCHEMBL15761660 | 0.92 | MEN1 (0.53) | CYP3A4SLC5A7MEN1LMNAKMT2A | |
| Fluoride Ion SCHEMBL190626 | 0.92 | MEN1 (0.53) | CYP3A4SLC5A7MEN1LMNAKMT2A | |
| SCHEMBL10416317 | 0.92 | MEN1 (0.53) | CYP3A4SLC5A7MEN1LMNAKMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 107 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4204609-B1 | COMPOSITIONS AND METHODS FOR THE ELECTRODEPOSITION OF NANOTWINNED COPPER | MACDERMID ENTHONE INC (US) | 2026-05-27 | — | — | EP | claimed |
| US-20260078517-A1 | COMPOSITION AND METHOD FOR NANOTWINNED COPPER FORMATION | MACDERMID ENTHONE INC (US) | 2026-03-19 | — | — | US | claimed |
| US-20260015560-A1 | COMPOSITIONS FOR POST-CMP CLEANING OF MICROELECTRONIC DEVICES | ENTEGRIS INC (US) | 2026-01-15 | — | — | US | claimed |
| CN-120051593-A | Compositions and methods for nano twinned copper formation | 麦克德米德乐思公司 | 2025-05-27 | — | — | CN | claimed |
| US-20240318342-A1 | COMPOSITIONS AND METHODS FOR THE ELETRODEPOSITION OF NANOTWINNED COPPER | MACDERMID ENTHONE INC. | 2024-09-26 | — | — | US | claimed |
| EP-4381120-A1 | COMPOSITIONS AND METHODS FOR THE ELECTRODEPOSITION OF NANOTWINNED COPPER | MacDermid Enthone Inc. (US) | 2024-06-12 | — | — | EP | claimed |
| WO-2024081584-A1 | COMPOSITION AND METHOD FOR NANOTWINNED COPPER FORMATION | MACDERMID ENTHONE INC. (US) | 2024-04-18 | — | — | WO | claimed |
| US-20240110306-A1 | Compositions and Methods for the Electrodeposition of Nanotwinned Copper | MACDERMID ENTHONE INC (US) | 2024-04-04 | — | — | US | claimed |
| CN-117795135-A | Compositions and methods for electrodepositing nano twinned copper | 麦克德米德乐思公司 | 2024-03-29 | — | — | CN | claimed |
| US-11873568-B2 | Compositions and methods for the electrodeposition of nanotwinned copper | MACDERMID ENTHONE INC. (US) | 2024-01-16 | — | — | US | claimed |
| US-10449483-B2 | Gas sweetening solvents containing quaternary ammonium salts | DOW GLOBAL TECHNOLOGIES LLC (US) | 2019-10-22 | — | — | US | claimed |
| US-20180179473-A1 | FABRIC SOFTENER COMPOSITION HAVING IMPROVED DETERGENT SCAVENGER COMPATIBILITY | THE PROCTER & GAMBLE COMPANY | 2018-06-28 | — | — | US | claimed |
| US-20160206992-A1 | GAS SWEETENING SOLVENTS CONTAINING QUATERNARY AMMONIUM SALTS | DOW GLOBAL TECHNOLOGIES LLC | 2016-07-21 | — | — | US | claimed |
| EP-3038736-A1 | GAS SWEETENING SOLVENTS CONTAINING QUATERNARY AMMONIUM SALTS | Dow Global Technologies LLC (US) | 2016-07-06 | — | — | EP | claimed |
| US-6379500-B2 | Silica-based sols | AKZO NOBEL NV (NL) | 2002-04-30 | — | — | US | claimed |
| US-20010004927-A1 | Aqueous silica-based sol comprising a nitrogen-containing organic compound and silica-based particles with a specific surface area of atleast 300 square meters/gram of silica having S-valule 10-60% | AKZO NOBEL NV (NL) | 2001-06-28 | — | — | US | claimed |
| US-5242463-A | Fibers, threads, linters, roving, fabrics, yarns, slivers and paper | THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF AGRICULTURE (US) | 1993-09-07 | — | — | US | claimed |
| US-5197544-A | Stimulating hydrocarbon production | HALLIBURTON COMPANY (US) | 1993-03-30 | — | — | US | claimed |
| EP-0501776-A1 | Stabilization of subterranean formations | HALLIBURTON COMPANY (US) | 1992-09-02 | — | — | EP | claimed |
| US-4264364-A | A COMPLEX OF A FRIEDEL-CRAFTS HALIDE WITH AN ORGANIC COMPOUND COMPRISING A QUATERNARY AMMONIUM, A PHOSPHONIUM, A SULFONIUM, OR AN ORTHO SILICATE COMPOUND | INDIAN HEAD INC. (US) | 1981-04-28 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260078517-A1 | COMPOSITION AND METHOD FOR NANOTWINNED COPPER FORMATION | AOC2, HCN2, STMN2 | CYP3A4 3517/4885SLC5A7 1882/4885MEN1 979/4885 |
| US-20260015560-A1 | COMPOSITIONS FOR POST-CMP CLEANING OF MICROELECTRONIC DEVICES | TET2, ASIC1, PIEZO1 | CYP3A4 4239/4885SLC5A7 1138/4885MEN1 2976/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.